BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12547153)

  • 1. A subgroup of malignant fibrous histiocytomas is associated with genetic changes similar to those of well-differentiated liposarcomas.
    Chibon F; Mariani O; Derré J; Malinge S; Coindre JM; Guillou L; Lagacé R; Aurias A
    Cancer Genet Cytogenet; 2002 Nov; 139(1):24-9. PubMed ID: 12547153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity.
    Coindre JM; Hostein I; Maire G; Derré J; Guillou L; Leroux A; Ghnassia JP; Collin F; Pedeutour F; Aurias A
    J Pathol; 2004 Jul; 203(3):822-30. PubMed ID: 15221942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASK1 (MAP3K5) as a potential therapeutic target in malignant fibrous histiocytomas with 12q14-q15 and 6q23 amplifications.
    Chibon F; Mariani O; Derré J; Mairal A; Coindre JM; Guillou L; Sastre X; Pédeutour F; Aurias A
    Genes Chromosomes Cancer; 2004 May; 40(1):32-7. PubMed ID: 15034865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-catenin accumulation and gene mutation in exon 3 in dedifferentiated liposarcoma and malignant fibrous histiocytoma.
    Sakamoto A; Oda Y; Adachi T; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Arch Pathol Lab Med; 2002 Sep; 126(9):1071-8. PubMed ID: 12204056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma.
    Coindre JM; Mariani O; Chibon F; Mairal A; De Saint Aubain Somerhausen N; Favre-Guillevin E; Bui NB; Stoeckle E; Hostein I; Aurias A
    Mod Pathol; 2003 Mar; 16(3):256-62. PubMed ID: 12640106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of well-differentiated/de-differentiated liposarcomas by high-resolution oligonucleotide array-based comparative genomic hybridization.
    Tap WD; Eilber FC; Ginther C; Dry SM; Reese N; Barzan-Smith K; Chen HW; Wu H; Eilber FR; Slamon DJ; Anderson L
    Genes Chromosomes Cancer; 2011 Feb; 50(2):95-112. PubMed ID: 21117066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myxoid malignant fibrous histiocytoma and pleomorphic liposarcoma share very similar genomic imbalances.
    Idbaih A; Coindre JM; Derré J; Mariani O; Terrier P; Ranchère D; Mairal A; Aurias A
    Lab Invest; 2005 Feb; 85(2):176-81. PubMed ID: 15702084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gains of 13q are correlated with a poor prognosis in liposarcoma.
    Schmidt H; Bartel F; Kappler M; Würl P; Lange H; Bache M; Holzhausen HJ; Taubert H
    Mod Pathol; 2005 May; 18(5):638-44. PubMed ID: 15540119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative genomic hybridization reveals novel chromosome deletions in 90 primary soft tissue tumors.
    Parente F; Grosgeorge J; Coindre JM; Terrier P; Vilain O; Turc-Carel C
    Cancer Genet Cytogenet; 1999 Dec; 115(2):89-95. PubMed ID: 10598139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pairwise comparison of genomic imbalances between primary and recurrent well differentiated liposarcomas.
    Micci F; Bjerkehagen B; Heim S
    Cancer Genet Cytogenet; 2007 Oct; 178(2):163-7. PubMed ID: 17954275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative genomic hybridization as a tool to define two distinct chromosome 12-derived amplification units in well-differentiated liposarcomas.
    Suijkerbuijk RF; Olde Weghuis DE; Van den Berg M; Pedeutour F; Forus A; Myklebost O; Glier C; Turc-Carel C; Geurts van Kessel A
    Genes Chromosomes Cancer; 1994 Apr; 9(4):292-5. PubMed ID: 7519052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of large chromosome markers in a malignant fibrous histiocytoma by spectral karyotyping, comparative genomic hybridization (CGH), and array CGH.
    Weng WH; Wejde J; Ahlén J; Pang ST; Lui WO; Larsson C
    Cancer Genet Cytogenet; 2004 Apr; 150(1):27-32. PubMed ID: 15041220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [From cytogenetics to cytogenomics of adipose tissue tumors: 2. Malignant adipose tissue tumors].
    Pedeutour F; Maire G; Sirvent N;
    Bull Cancer; 2004 Apr; 91(4):317-23. PubMed ID: 15242313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RB1 gene is the target of chromosome 13 deletions in malignant fibrous histiocytoma.
    Chibon F; Mairal A; Fréneaux P; Terrier P; Coindre JM; Sastre X; Aurias A
    Cancer Res; 2000 Nov; 60(22):6339-45. PubMed ID: 11103795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
    Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
    Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leiomyosarcoma and malignant fibrous histiocytoma share similar allelic imbalance pattern at 9p.
    Sabah M; Cummins R; Leader M; Kay E
    Virchows Arch; 2005 Mar; 446(3):251-8. PubMed ID: 15731925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLS-CHOP target gene DOL54 expression in liposarcomas and malignant fibrous histiocytomas.
    Domoto H; Hosaka T; Oikawa K; Ohbayashi T; Ishida T; Izumi M; Iwaya K; Toguchida J; Kuroda M; Mukai K
    Pathol Int; 2002 Aug; 52(8):497-500. PubMed ID: 12366807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of chromosome 13 is the most frequent genomic imbalance in malignant fibrous histiocytomas. A comparative genomic hybridization analysis of a series of 30 cases.
    Mairal A; Terrier P; Chibon F; Sastre X; Lecesne A; Aurias A
    Cancer Genet Cytogenet; 1999 Jun; 111(2):134-8. PubMed ID: 10347550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct chromosomal imbalances in pleomorphic and in high-grade dedifferentiated liposarcomas.
    Rieker RJ; Joos S; Bartsch C; Willeke F; Schwarzbach M; Otaño-Joos M; Ohl S; Högel J; Lehnert T; Lichter P; Otto HF; Mechtersheimer G
    Int J Cancer; 2002 May; 99(1):68-73. PubMed ID: 11948494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H-ras oncogene mutation in dedifferentiated liposarcoma. Polymerase chain reaction-restriction fragment length polymorphism analysis.
    Sakamoto A; Oda Y; Adachi T; Tamiya S; Matsuda S; Tanaka K; Iwamoto Y; Tsuneyoshi M
    Am J Clin Pathol; 2001 Feb; 115(2):235-42. PubMed ID: 11211612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.